ID: ALA4444836
Max Phase: Preclinical
Molecular Formula: C13H15F3N4S
Molecular Weight: 316.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: FC(F)(F)Cc1cc2c(NC3CCNCC3)ncnc2s1
Standard InChI: InChI=1S/C13H15F3N4S/c14-13(15,16)6-9-5-10-11(18-7-19-12(10)21-9)20-8-1-3-17-4-2-8/h5,7-8,17H,1-4,6H2,(H,18,19,20)
Standard InChI Key: CAECZTJRDHCXAW-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 316.35 | Molecular Weight (Monoisotopic): 316.0970 | AlogP: 2.96 | #Rotatable Bonds: 3 |
| Polar Surface Area: 49.84 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.98 | CX LogP: 2.28 | CX LogD: -0.21 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.91 | Np Likeness Score: -1.56 |
| 1. Ren J, Xu W, Tang L, Su M, Chen D, Chen YL, Zang Y, Li J, Shen J, Zhou Y, Xiong B.. (2016) Design and synthesis of benzylpiperidine inhibitors targeting the menin-MLL1 interface., 26 (18): [PMID:27528435] [10.1016/j.bmcl.2016.07.074] |
Source(1):
